- Future Growth of the insulin market will be led
by greater consumption of analog insulin - Market leaders are concentrating upon R&D
in the country
Ken
Research announced its latest publication on “China Insulin Market Review to 2018 - Increasing Focus on R&D
Investments” which provides a comprehensive analysis of major types of
insulin consumed in the country. The report covers various aspects such as
market size of China’s insulin market, segmentation on the basis of insulin
replacement therapy, types of insulin, usage by type of diabetes and future
outlook of the market. The report is useful for insulin manufacturers and
distributors, as well as new players venturing in the market.
Research announced its latest publication on “China Insulin Market Review to 2018 - Increasing Focus on R&D
Investments” which provides a comprehensive analysis of major types of
insulin consumed in the country. The report covers various aspects such as
market size of China’s insulin market, segmentation on the basis of insulin
replacement therapy, types of insulin, usage by type of diabetes and future
outlook of the market. The report is useful for insulin manufacturers and
distributors, as well as new players venturing in the market.
In view of China
accounting for the largest patient pool of diabetes in the world, in addition
to the growing spending power of the population, insulin majors such as Novo
Nordisk, Eli Lilly and Company and Sanofi are intensifying their R&D and
production activities in the country. In
order to provide products that are more localized that suit the specific needs
of China’s diabetic population, companies are increasingly investing towards
R&D in the country.
accounting for the largest patient pool of diabetes in the world, in addition
to the growing spending power of the population, insulin majors such as Novo
Nordisk, Eli Lilly and Company and Sanofi are intensifying their R&D and
production activities in the country. In
order to provide products that are more localized that suit the specific needs
of China’s diabetic population, companies are increasingly investing towards
R&D in the country.
According to the
research report, the Chinese insulin market will grow rapidly, thereby exceeding
USD 3 billion by 2018, largely due to rapidly increasing consumption of analog
insulin in the country.
research report, the Chinese insulin market will grow rapidly, thereby exceeding
USD 3 billion by 2018, largely due to rapidly increasing consumption of analog
insulin in the country.
“Since China is
on its way to become the largest market for insulin in the Asia Pacific as well
as globally, insulin companies are strengthening their R&D in the country”,
according
to the Research Associate, Ken Research.
on its way to become the largest market for insulin in the Asia Pacific as well
as globally, insulin companies are strengthening their R&D in the country”,
according
to the Research Associate, Ken Research.
Key
Topics Covered in the Report:
Topics Covered in the Report:
-
China Insulin Market Size by Volume and Value
China Insulin Market Size by Volume and Value
-
Market Segmentation by insulin replacement
therapy and types of insulin
Market Segmentation by insulin replacement
therapy and types of insulin
-
Trends and growth drivers
Trends and growth drivers
-
Competition and Market Share
Competition and Market Share
-
Future Outlook
Future Outlook
-
Macro Economic Parameters
Macro Economic Parameters
Key
Products Mentioned in the Report
Products Mentioned in the Report
Human Insulin
Analog Insulin
Premix Insulin
Rapid Acting Insulin
Long Acting Insulin
Companies
Covered in the Report
Covered in the Report
Novo Nordisk
Eli Lilly and Company
Sanofi Aventis
BJ Ganli Pharmaceuticals
Tonghua Dongbao
Browse and Download
Report Here - http://www.kenresearch.com/healthcare/pharmaceutical-industry/china-insulin-market-research-report/574-91.html
Report Here - http://www.kenresearch.com/healthcare/pharmaceutical-industry/china-insulin-market-research-report/574-91.html
Related Reports:
Contact:
Ken Research
Information Department
info@kenresearch.com
+91-011-47017199
Ken Research
Information Department
info@kenresearch.com
+91-011-47017199
No comments:
Post a Comment